Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
Publication
, Journal Article
Lopes, RD; Rordorf, R; De Ferrari, GM; Leonardi, S; Wallentin, L
Published in: J Am Coll Cardiol
July 3, 2018
Duke Scholars
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 3, 2018
Volume
72
Issue
1
Start / End Page
125 / 126
Location
United States
Related Subject Headings
- Humans
- Digoxin
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anti-Arrhythmia Agents
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., Rordorf, R., De Ferrari, G. M., Leonardi, S., & Wallentin, L. (2018). Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed. J Am Coll Cardiol, 72(1), 125–126. https://doi.org/10.1016/j.jacc.2018.04.045
Lopes, Renato D., Roberto Rordorf, Gaetano M. De Ferrari, Sergio Leonardi, and Lars Wallentin. “Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.” J Am Coll Cardiol 72, no. 1 (July 3, 2018): 125–26. https://doi.org/10.1016/j.jacc.2018.04.045.
Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Wallentin L. Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed. J Am Coll Cardiol. 2018 Jul 3;72(1):125–6.
Lopes, Renato D., et al. “Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.” J Am Coll Cardiol, vol. 72, no. 1, July 2018, pp. 125–26. Pubmed, doi:10.1016/j.jacc.2018.04.045.
Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Wallentin L. Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed. J Am Coll Cardiol. 2018 Jul 3;72(1):125–126.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 3, 2018
Volume
72
Issue
1
Start / End Page
125 / 126
Location
United States
Related Subject Headings
- Humans
- Digoxin
- Cardiovascular System & Hematology
- Atrial Fibrillation
- Anti-Arrhythmia Agents
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology